Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
6.11
+0.01 (0.19%)
Sep 1, 2026, 3:04 PM EDT - Market open
Aardvark Therapeutics Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Aardvark Therapeutics stock has a consensus rating of "Buy" and an average price target of $14.5. The average 1-year stock price forecast is 137.26% higher than the current stock price, while the lowest is $3.00 (-50.91%) and the highest is $45 (+636.33%).
Price Target: $14.5 (+137.26%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aardvark Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 6 | 6 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Sell Maintains n/a | Sell | Maintains | n/a | n/a | Aug 14, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Reiterates $6 | Hold | Reiterates | $6 | -1.82% | Aug 13, 2026 |
| BTIG | BTIG | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 13, 2026 |
| Morgan Stanley | Morgan Stanley | Sell Reiterates $3 | Sell | Reiterates | $3 | -50.91% | Aug 12, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $6 | Hold | Maintains | $6 | -1.82% | Aug 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.17
from -2.93
EPS Next Year
-2.78
from -3.17
EPS and Forward PE are based on non-GAAP adjusted numbers.